🔎 Trials Near Me

Home › Myotonic Dystrophy

Myotonic Dystrophy clinical trials recruiting in the U.S.

19 studies for Myotonic Dystrophy are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

RecruitingPhase 3
Ages 16 and older · All sexes · Updated Nov 13, 2026 · NCT07486934

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

RecruitingObservational study
59 Months · All sexes · Updated Nov 3, 2026 · NCT05224778

Metabolomic Biomarkers of Myotonic Dystrophy

RecruitingObservational studyHealthy volunteers welcome
Ages 14 and older · All sexes · Updated Nov 3, 2026 · NCT07912983

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Nov 3, 2026 · NCT03981575

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy

RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06075693

Biomarker Development for Muscular Dystrophies

RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Oct 29, 2026 · NCT05019625

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Oct 16, 2026 · NCT07700225

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

Recruiting
Ages 18 to 70 · All sexes · Updated Oct 8, 2026 · NCT06716931

Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension

RecruitingObservational study
Ages 3 to 17 · All sexes · Updated Aug 11, 2026 · NCT06747884

Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy

RecruitingObservational study
Ages 0 to 17 · All sexes · Updated Jun 5, 2026 · NCT07630389

Remote Assessments and Genetic Determinants of Myotonic Dystrophy

RecruitingObservational study
Ages 18 to 88 · All sexes · Updated Apr 1, 2026 · NCT07505342

Study of ATX-01 in Participants With DM1

RecruitingPhase 1/2
Ages 18 to 64 · All sexes · Updated Feb 10, 2026 · NCT06300307

Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Jan 23, 2026 · NCT07362875

Long-Term Development of Muscular Dystrophy Outcome Assessments

RecruitingObservational study
Ages 6 to 50 · All sexes · Updated Nov 18, 2025 · NCT05989620

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Oct 15, 2025 · NCT00082108

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

RecruitingPhase 2/3
Ages 6 to 45 · All sexes · Updated May 28, 2025 · NCT05004129

Myotonic Dystrophy Family Registry

RecruitingObservational study
All ages · All sexes · Updated Nov 21, 2024 · NCT02398786

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.